BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 17968338)

  • 1. Therapy insight: how the gut talks to the joints--inflammatory bowel disease and the spondyloarthropathies.
    Meier C; Plevy S
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):667-74. PubMed ID: 17968338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.
    Karimi O; Peña AS
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intestines and joints: an entity?].
    De Vos M
    Verh K Acad Geneeskd Belg; 2002; 64(2):85-99; discussion 99-104. PubMed ID: 12085568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bowel lesions in spondyloarthritides.
    Rimbaş M; Marinescu M; Voiosu MR
    Rom J Intern Med; 2009; 47(1):75-85. PubMed ID: 19886073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics in arthralgia and spondyloarthropathies in patients with inflammatory bowel disease. Prospective randomized trials are necessary.
    Karimi O; Peña AS
    Rev Esp Enferm Dig; 2005 Aug; 97(8):570-4. PubMed ID: 16266224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach.
    Targan SR; Karp LC
    Curr Opin Gastroenterol; 2007 Jul; 23(4):390-4. PubMed ID: 17545774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spondyloarthropathies: an overview.
    Stafford L; Youssef PP
    Intern Med J; 2002; 32(1-2):40-6. PubMed ID: 11783674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: joint involvement in inflammatory bowel disease.
    De Vos M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():36-42. PubMed ID: 15352892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteria in the pathogenesis of inflammatory bowel disease.
    Subramanian S; Campbell BJ; Rhodes JM
    Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut and spondyloarthropathies.
    Leirisalo-Repo M; Repo H
    Rheum Dis Clin North Am; 1992 Feb; 18(1):23-35. PubMed ID: 1561404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut flora in health and disease: potential role of probiotics.
    Heselmans M; Reid G; Akkermans LM; Savelkoul H; Timmerman H; Rombouts FM
    Curr Issues Intest Microbiol; 2005 Mar; 6(1):1-7. PubMed ID: 15751747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spondyloarthropathies: progress and challenges.
    Jacques P; Mielants H; De Vos M; Elewaut D
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):325-37. PubMed ID: 18455688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
    Rogler G
    Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of spondylarthropathy in inflammatory bowel disease.
    Generini S; Fiori G; Matucci Cerinic M
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S88-94. PubMed ID: 12463455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.